CopyMark Law Group
4.9/5
Drawing for COLOSIGHT

USPTO serial 97119480

COLOSIGHT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CAHILL, CLARE GALLAGHER
Law office
TMEG LAW OFFICE 104

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COLOSIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Smith

Matthew J. Smith POLSINELLI PC100 S. FOURTH ST.SUITE 1000ST. LOUIS, MO 63102

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic biomarkers for medical purposes for detecting cancer; Diagnostic preparations for medical purposes; biological preparations for the treatment of cancerACTIVE—
035Compilation of information into computer databases, namely, inputting and collection of data and information in the field of cancer information for treatment and diagnostic purposesACTIVE—
044Medical screening services in the field of cancer; Medical analysis for the diagnosis and treatment of cancer; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes in the field of cancer; Health care services, namely, for treating cancer; medical diagnosis and treatment of cancer; medical diagnosis of cancer; medical evaluation of cancer; medical services in the field of cancer; medical diagnostic services in the field of testing for cancer markers, including in a patient's excrement such as stool samples; providing a website featuring information in the field of the diagnosis and treatment of cancer; providing cancer screening services; providing information in the field of cancer prevention, screening, diagnosis and treatment; providing an on-line computer database in the field of cancer information for treatment and diagnostic purposes; providing information relating to diagnostics in the nature of medical diagnostic testing, monitoring and reporting informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 21, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 21, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2024EX4GSOU EXTENSION 4 GRANTED—
Dec 16, 2024EXT4SOU EXTENSION 4 FILED—
Dec 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 12, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 12, 2024EX3GSOU EXTENSION 3 GRANTED—
Jun 12, 2024EXT3SOU EXTENSION 3 FILED—
Jun 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 20, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 18, 2023EX2GSOU EXTENSION 2 GRANTED—
Dec 18, 2023EXT2SOU EXTENSION 2 FILED—
Dec 18, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 20, 2023EX1GSOU EXTENSION 1 GRANTED—
Jun 20, 2023EXT1SOU EXTENSION 1 FILED—
Jun 20, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 20, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 16, 2022CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Dec 7, 2022APETASSIGNED TO PETITION STAFF—
Nov 16, 2022EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 15, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2022DOCKASSIGNED TO EXAMINER—
Nov 18, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 15, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance